Bio-Rad Laboratories's market cap is currently $8.65B. The company's EPS TTM is $2.26; its P/E ratio is 27.23; Bio-Rad Laboratories is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $2.82. See an overview of income statement, balance sheet, and cash flow financials.
